BlueCrest Capital Management’s Xylem XYL Stock Holding History

BlueCrest Capital Management’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-5,559	Closed	-$379K	–	1658
2017 Q4	$379K	Buy	5,559 +1,433	+35%	+$95.1K	0.01%	581
2017 Q3	$258K	Sell	4,126 -225,259	-98%	-$13.5M	0.01%	673
2017 Q2	$12.7M	Buy	229,385 +218,939	+2,096%	+$11.4M	0.49%	34
2017 Q1	$525K	Buy	+10,446	New	+$509K	0.02%	427
2016 Q3	–	Sell	-15,000	Closed	-$670K	–	1027
2016 Q2	$670K	Buy	+15,000	New	+$652K	0.03%	445
2015 Q4	–	Sell	-72,070	Closed	-$2.37M	–	1215
2015 Q3	$2.37M	Buy	+72,070	New	+$2.42M	0.08%	247
2015 Q2	–	Sell	-67,273	Closed	-$2.36M	–	936
2015 Q1	$2.36M	Buy	+67,273	New	+$2.37M	0.13%	228

Other funds holding XYL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

IAMU

Impax Asset Management (UK) London, United Kingdom $4.12B AUM 10.79% 1-Year Est. Return

BlueCrest Capital Management's XYL Position: Q1 2018 in Review

BlueCrest Capital Management sold out of Xylem (XYL) in Q1 2018, closing a stake of 5,559 shares — an estimated $379K sold.

BlueCrest Capital Management first reported a position in XYL in Q1 2015 and held it in 7 quarters. The position peaked at $12.7M in Q2 2017. 639 funds tracked by Wall St. Rank hold XYL as of Q1 2018.

BlueCrest Capital Management reported no remaining Xylem position as of Q1 2018 after selling out during the quarter.
BlueCrest Capital Management sold 5,559 Xylem shares in Q1 2018, an estimated $379K.
BlueCrest Capital Management first reported a position in Xylem in Q1 2015 and held it in 7 quarters.
BlueCrest Capital Management's Xylem position peaked at $12.7M in Q2 2017.
639 funds tracked by Wall St. Rank held Xylem as of Q1 2018.

Based on BlueCrest Capital Management's 13F filing for Q1 2018, filed 15 May 2018.